Granata Bio is identifying and developing therapies that can help fertility patients. The biggest barrier to fertility treatment in the US is cost with the price for IVF treatments rising 50% since 2014. Granata’s model is to identify and in-license strategic medications used in IVF outside of the US for clinical development and commercialization in North America. Currently, Granata has five drug programs in their pipeline that are either already commercially available or are in late-stage clinical trials.

Granata Bio

Founded: 2018
Location: Duxbury, MA
Employee range: 1 - 10
Clinical stage: COM
Therapy area: Hormonal control in fertility treatments
Drug types: OBG, IMM
Lead product: Ganirelix Acetate (partner: Amphastar)

Drug notes:

About:

Jobs: